{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:19:44Z","timestamp":1778602784690,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Boehringer Ingelheim"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00508-018-1347-7","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T12:27:05Z","timestamp":1527164825000},"page":"382-389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phenotypes of COPD in an Austrian population"],"prefix":"10.1007","volume":"130","author":[{"given":"Gabriele","family":"Reiger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Zwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"K\u00e4hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto Chris","family":"Burghuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arschang","family":"Valipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"1347_CR1","volume-title":"Global strategy for the diagnosis, management and prevention of COPD","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2016","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2016. \n                    http:\/\/goldcopd.org\/\n                    \n                   (Created 1 Feb 2016). Accessed 26 May 2016."},{"issue":"2","key":"1347_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000354796","volume":"87","author":"G Weiss","year":"2014","unstructured":"Weiss G, Steinacher I, Lamprecht B, Schirnhofer L, Kaiser B, S\u00f6nnichsen A, Studnicka M. Detection of chronic obstructive pulmonary disease in primary care in Salzburg, Austria: findings from the real world. Respiration. 2014;87(2):136\u201343.","journal-title":"Respiration"},{"issue":"17\u201318","key":"1347_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00508-007-0867-3","volume":"119","author":"N Firlei","year":"2007","unstructured":"Firlei N, Lamprecht B, Schirnhofer L, Kaiser B, Studnicka M. The prevalence of COPD in Austria\u2014the expected change over the next decade. Wien Klin Wochenschr. 2007;119(17\u201318):513\u20138.","journal-title":"Wien Klin Wochenschr"},{"key":"1347_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","volume":"182","author":"MK Han","year":"2010","unstructured":"Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598\u2013604.","journal-title":"Am J Respir Crit Care Med"},{"key":"1347_CR5","first-page":"611","volume":"11","author":"Z Zbozinkova","year":"2016","unstructured":"Zbozinkova Z, Barczyk A, Tkacova R, Valipour A, Tudoric N, Zykov K, Somfay A, Miravitlles M, Koblizek V. POPE study: rationale and methodology of a\u00a0study to phenotype patients with COPD in Central and Eastern Europe. Int J Chron Obstruct Pulmon Dis. 2016;11:611\u201322.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1347_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J\u00a0Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"1347_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. ATS\/ERS Task Force. Standardisation of spirometry. Eur Respir\u00a0J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"1347_CR8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir\u00a0J. 2005;26:948\u201368.","journal-title":"Eur Respir J"},{"key":"1347_CR9","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1183\/09031936.98.11061354","volume":"11","author":"J Roca","year":"1998","unstructured":"Roca J, Burgos F, Sunyer J, Saez M, Chinn S, Ant\u00f3 JM, Rodr\u00edguez-Roisin R, Quanjer PH, Nowak D, Burney P, Group of the European Community Respiratory Health Survey. References values for forced spirometry. Eur Respir\u00a0J. 1998;11:1354\u201362.","journal-title":"Eur Respir J"},{"key":"1347_CR10","first-page":"3","volume":"11","author":"P Lange","year":"2016","unstructured":"Lange P, Halpin DM, O\u2019Donnell DE, MacNee W. Diagnosis, assessment, and phenotyping of COPD: beyond FEV1. Int J Chron Obstruct Pulmon Dis. 2016;11:3\u201312.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1183\/09031936.00062211","volume":"38","author":"A Agust\u00ed","year":"2011","unstructured":"Agust\u00ed A, Celli B. Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. Eur Respir\u00a0J. 2011;38:749\u201351.","journal-title":"Eur Respir J"},{"key":"1347_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1183\/13993003.01170-2015","volume":"47","author":"M Miravitlles","year":"2016","unstructured":"Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, Kankaanranta H, Sandstr\u00f6m T, \u015aliwi\u0144ski P, Zatloukal J, Blasi F. A review of national guidelines for management of COPD in Europe. Eur Respir\u00a0J. 2016;47:625\u201337.","journal-title":"Eur Respir J"},{"issue":"5","key":"1347_CR13","doi-asserted-by":"publisher","first-page":"1601446","DOI":"10.1183\/13993003.01446-2016","volume":"49","author":"V Koblizek","year":"2017","unstructured":"Koblizek V, Milenkovic B, Barczyk A, Tkacova R, Somfay A, Zykov K, Tudoric N, Kostov K, Zbozinkova Z, Svancara J, Sorli J, Krams A, Miravitlles M, Valipour A. Phenotypes of COPD patients with a\u00a0smoking history in Central and Eastern Europe: the POPE Study. Eur Respir\u00a0J. 2017;49(5):1601446.","journal-title":"Eur Respir J"},{"issue":"9","key":"1347_CR14","doi-asserted-by":"publisher","first-page":"e0160770","DOI":"10.1371\/journal.pone.0160770","volume":"11","author":"BG Cosio","year":"2016","unstructured":"Cosio BG, Soriano JB, L\u00f3pez-Campos JL, Calle M, Soler JJ, de-Torres JP, Mar\u00edn JM, Mart\u00ednez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I. CHAIN study. Distribution and outcomes of a\u00a0phenotype-based approach to guide COPD management: results from the CHAIN cohort. PLoS ONE. 2016;11(9):e160770.","journal-title":"PLoS ONE"},{"key":"1347_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/COPD.S36997","volume":"7","author":"MK Pasquale","year":"2012","unstructured":"Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a\u00a0predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757\u201364.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1347_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.rmed.2014.12.001","volume":"109","author":"A Lindberg","year":"2015","unstructured":"Lindberg A, Sawalha S, Hedman L, Larsson LG, Lundb\u00e4ck B, R\u00f6nmark E. Subjects with COPD and productive cough have an increased risk for exacerbations and death. Respir Med. 2015;109:88\u201395.","journal-title":"Respir Med"},{"key":"1347_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)62410-7","volume":"385","author":"FJ Martinez","year":"2015","unstructured":"Martinez FJ, Calverley PM, Goehring UM, Brose M, Fabbri LM, Rabe KF. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a\u00a0multicentre randomised controlled trial. Lancet. 2015;385:857\u201366.","journal-title":"Lancet"},{"issue":"8","key":"1347_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.rmed.2014.05.013","volume":"108","author":"JA Wedzicha","year":"2014","unstructured":"Wedzicha JA, Singh D, Vestbo J, Paggiaro PL, Jones PW, Bonnet-Gonod F, Cohuet G, Corradi M, Vezzoli S, Petruzzelli S, Agusti A, FORWARD Investigators. Extrafine beclomethasone\/formoterol in severe COPD patients with history of exacerbations. Respir Med. 2014;108(8):1153\u201362.","journal-title":"Respir Med"},{"key":"1347_CR19","volume-title":"Global strategy for asthma management and prevention","author":"GINA","year":"2016","unstructured":"GINA. Global strategy for asthma management and prevention. 2016. \n                    http:\/\/ginasthma.org\/\n                    \n                   (Created 1 Feb 2016). Accessed 26 May 2016."},{"key":"1347_CR20","first-page":"551","volume":"9","author":"DB Price","year":"2014","unstructured":"Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. Int J Chron Obstruct Pulmon Dis. 2014;9:551\u201361.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1347_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.rmed.2012.03.008","volume":"106","author":"A Corrado","year":"2012","unstructured":"Corrado A, Rossi A. How far is real life from COPD therapy guidelines? An Italian observational study. Respir Med. 2012;106:989\u201397.","journal-title":"Respir Med"},{"key":"1347_CR22","first-page":"39","volume":"10","author":"KJ Davis","year":"2014","unstructured":"Davis KJ, Landis SH, Oh YM, Mannino DM, Han MK, van der Molen T, Aisanov Z, Menezes AM, Ichinose M, Muellerova H. Continuing to confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries. Int J Chron Obstruct Pulmon Dis. 2014;10:39\u201355.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1347_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/COPD.S16396","volume":"6","author":"GD Salinas","year":"2011","unstructured":"Salinas GD, Williamson JC, Kalhan R, Thomashow B, Scheckermann JL, Walsh J, Abdolrasulnia M, Foster JA. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. Int J Chron Obstruct Pulmon Dis. 2011;6:171\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1347_CR24","first-page":"159","volume":"10","author":"AM Menezes","year":"2015","unstructured":"Menezes AM, Landis SH, Han MK, Muellerova H, Aisanov Z, van der Molen T, Oh YM, Ichinose M, Mannino DM, Davis KJ. Continuing to confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management. Int J Chron Obstruct Pulmon Dis. 2015;10:159\u201372.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1347_CR25","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.3399\/bjgp12X625111","volume":"62","author":"M Miravitlles","year":"2012","unstructured":"Miravitlles M, Andreu I, Romero Y, Sitjar S, Alt\u00e9s A, Anton E. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract. 2012;62:e68\u2013e75.","journal-title":"Br J Gen Pract"},{"key":"1347_CR26","volume-title":"Global strategy for the diagnosis, management and prevention of COPD","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2017","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2017. \n                    http:\/\/goldcopd.org\/\n                    \n                  . Accessed 8 Jan 2017."},{"issue":"4","key":"1347_CR27","doi-asserted-by":"publisher","first-page":"1602518","DOI":"10.1183\/13993003.02518-2016","volume":"49","author":"N Tudoric","year":"2017","unstructured":"Tudoric N, Koblizek V, Miravitlles M, Valipour A, Milenkovic B, Barczyk A, Somfay A, Zykov K, Kostov K, Zbozinkova Z, Svoboda M, Sorli J, Krams A, Tkacova R. GOLD 2017 on the way to a\u00a0phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort. Eur Respir\u00a0J. 2017;49(4):1602518.","journal-title":"Eur Respir J"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-018-1347-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-018-1347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-018-1347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T15:13:29Z","timestamp":1589901209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-018-1347-7"}},"subtitle":["National data from the POPE study"],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":27,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1007\/s00508-018-1347-7","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"11 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Valipour declares that he has received a\u00a0research grant from Boehringer Ingelheim for the current study. G.\u00a0Reiger, R.\u00a0Zwick, B.\u00a0Lamprecht, C.\u00a0K\u00e4hler, and O.C.\u00a0Burghuber declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}